Unique ID issued by UMIN | UMIN000032000 |
---|---|
Receipt number | R000036525 |
Scientific Title | A single center non randomized open-label comparative study using historical controls to verify the effectiveness of plasma exchange therapy for patients with anti-MDA 5 antibody positive rapidly progressive interstitial pneumonia |
Date of disclosure of the study information | 2018/04/01 |
Last modified on | 2023/04/04 09:58:09 |
A single center non randomized open-label comparative study using historical controls to verify the effectiveness of plasma exchange therapy for patients with anti-MDA 5 antibody positive rapidly progressive interstitial pneumonia
Efficacy of plasma exchange therapy for anti-MDA5 antibody positive interstitial pneumonia
A single center non randomized open-label comparative study using historical controls to verify the effectiveness of plasma exchange therapy for patients with anti-MDA 5 antibody positive rapidly progressive interstitial pneumonia
Efficacy of plasma exchange therapy for anti-MDA5 antibody positive interstitial pneumonia
Japan |
Interstitial pneumonia
Medicine in general |
Others
NO
Validate the usefulness of plasma exchange therapy for refractory anti-MDA5 antibody positive interstitial pneumonia
Efficacy
One year survival rate
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine | Device,equipment |
Plasma exchange.
Plasma exchange therapy should be performed once with 2.0 to 3.0 L and three times as one course. Nafamostat mesilate is used as an anticoagulant and fresh frozen plasma is used as a replenisher. Until the introduction of remission, the number of enforcement courses will be decided appropriately between 1 and 6 courses depending on the condition. For this reason, the total number of plasma exchange therapies ranges from 3 to a maximum of 18, resulting in a fresh frozen plasma transfusion volume of 6.0 L to 54.0 L.
20 | years-old | <= |
Not applicable |
Male and Female
Patient who was newly developed or relapsed this time diagnosed as anti-MDA5 antibody positive interstitial pneumonia which is treatment-resistant to standard treatment acquired agreement over 20 years in writing.
When there is withdrawal of consent of research cooperation from research subjects.
When the whole research is canceled.
In cases where the researcher judges that the cancellation of research is appropriate for other reasons.
When adverse reactions with difficult plasma continuation therapy appear.
5
1st name | Naoto |
Middle name | |
Last name | Tamura |
Juntendo university
Department of internal medicine and rheumatology
1130033
2-1-1, Hongo, Bunkyo-Ku, Tokyo, Japan
0338133111
tnaoto@juntendo.ac.jp
1st name | Yoshiyuki |
Middle name | |
Last name | Abe |
Juntendo university
Department of Internal Medicine and Rheumatology
1130033
2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan
0338133111
yo-abe@juntendo.ac.jp
Juntendo university
Self funding
Self funding
Juntendo University
2-1-1, Hongo, Bunkyo-Ku
0338133111
yo-abe@juntendo.ac.jp
NO
順天堂大学医学部附属順天堂醫院
2018 | Year | 04 | Month | 01 | Day |
https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000036525
Unpublished
https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000036525
0
No entry.
2023 | Year | 04 | Month | 04 | Day |
None
None
None
None
Terminated
2018 | Year | 03 | Month | 30 | Day |
2018 | Year | 03 | Month | 23 | Day |
2018 | Year | 04 | Month | 01 | Day |
2022 | Year | 03 | Month | 31 | Day |
2018 | Year | 03 | Month | 30 | Day |
2023 | Year | 04 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036525
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |